KE3258A - 21-halogenopregnane compounds - Google Patents

21-halogenopregnane compounds

Info

Publication number
KE3258A
KE3258A KE3258A KE325883A KE3258A KE 3258 A KE3258 A KE 3258A KE 3258 A KE3258 A KE 3258A KE 325883 A KE325883 A KE 325883A KE 3258 A KE3258 A KE 3258A
Authority
KE
Kenya
Prior art keywords
halogenopregnane
compounds
halogenopregnane compounds
Prior art date
Application number
KE3258A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of KE3258A publication Critical patent/KE3258A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KE3258A 1976-09-29 1983-01-21 21-halogenopregnane compounds KE3258A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (ja) 1976-09-29 1976-09-29

Publications (1)

Publication Number Publication Date
KE3258A true KE3258A (en) 1983-03-04

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3258A KE3258A (en) 1976-09-29 1983-01-21 21-halogenopregnane compounds

Country Status (24)

Country Link
JP (1) JPS5356652A (ja)
AT (3) AT363197B (ja)
AU (1) AU514200B2 (ja)
BE (1) BE859120A (ja)
CA (1) CA1101410A (ja)
CH (9) CH624967A5 (ja)
CY (1) CY1178A (ja)
DD (1) DD133150A5 (ja)
DE (1) DE2743069C2 (ja)
DK (1) DK146017C (ja)
ES (1) ES462763A1 (ja)
FR (1) FR2366311A1 (ja)
GB (1) GB1563638A (ja)
HK (1) HK16683A (ja)
HU (1) HU175218B (ja)
IE (1) IE46047B1 (ja)
IL (1) IL53012A (ja)
KE (1) KE3258A (ja)
LU (1) LU75903A1 (ja)
MY (1) MY8400092A (ja)
NL (1) NL7710089A (ja)
SE (1) SE436751B (ja)
SG (1) SG3383G (ja)
ZA (1) ZA775800B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
EP0523132A1 (en) * 1990-03-27 1993-01-20 Schering Corporation PROCESS FOR 9$g(a)-HYDROXY STEROID DEHYDRATION
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
CA2473471A1 (en) 2001-11-29 2003-06-12 Taro Pharmaceuticals U.S.A., Inc. Method for the preparation of 6-alpha-fluoro corticosteroids
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
AU2016279801B2 (en) 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
AT363197B (de) 1981-07-10
BE859120A (fr) 1978-03-28
CH632521A5 (en) 1982-10-15
ZA775800B (en) 1978-08-30
IE46047L (en) 1978-03-29
FR2366311A1 (fr) 1978-04-28
CA1101410A (en) 1981-05-19
DK146017C (da) 1983-10-24
JPS5356652A (en) 1978-05-23
CH625809A5 (en) 1981-10-15
CY1178A (en) 1983-06-10
DK146017B (da) 1983-05-24
GB1563638A (en) 1980-03-26
HU175218B (hu) 1980-06-28
AU2914877A (en) 1979-04-05
FR2366311B1 (ja) 1982-12-03
DE2743069C2 (de) 1987-03-05
IL53012A (en) 1982-05-31
ES462763A1 (es) 1978-05-16
HK16683A (en) 1983-05-27
AT363203B (de) 1981-07-27
NL7710089A (nl) 1978-03-31
IE46047B1 (en) 1983-02-09
SG3383G (en) 1983-09-09
AT363202B (de) 1981-07-27
CH632279A5 (en) 1982-09-30
CH625808A5 (en) 1981-10-15
ATA691077A (de) 1980-12-15
CH631999A5 (en) 1982-09-15
CH624967A5 (en) 1981-08-31
SE7706673L (sv) 1978-03-30
ATA151379A (de) 1980-12-15
IL53012A0 (en) 1977-11-30
DE2743069A1 (de) 1978-03-30
JPS6214557B2 (ja) 1987-04-02
ATA151279A (de) 1980-12-15
CH631998A5 (en) 1982-09-15
SE436751B (sv) 1985-01-21
LU75903A1 (ja) 1978-05-16
MY8400092A (en) 1984-12-31
CH632000A5 (en) 1982-09-15
DD133150A5 (de) 1978-12-13
DK256977A (da) 1978-03-30
AU514200B2 (en) 1981-01-29
CH625810A5 (en) 1981-10-15

Similar Documents

Publication Publication Date Title
IL48824A0 (en) Thc-type compounds
JPS52151348A (en) Compound
JPS5363424A (en) Bitumious compound
JPS52125197A (en) Transshexahydroopyridooindole compound
JPS5297994A (en) Betaalactummcontaining compounds
JPS5317639A (en) Hexakisazo compounds
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
GB1539364A (en) 11-deoxy-11-oxaprostaglandin compounds
JPS5295689A (en) Betaalactummcontaining compound
JPS5359686A (en) Compound
JPS5325537A (en) Compound
JPS5293772A (en) Indolinospiropyran compound
HK16683A (en) 21-halogenopregnane compounds
JPS5323995A (en) Antiibacterial compound
JPS5321222A (en) Bissbenzoxazolyl compound
JPS52156899A (en) Compound
JPS52111590A (en) Novel cephalospoline compounds
JPS5353692A (en) Antiiworm compound
JPS52102227A (en) Haloalkylphosphate compounds
ZA772175B (en) Oxothia compounds
JPS5285216A (en) Azamethineemetal complex compounds
JPS5353693A (en) Antiiworm compound
JPS5297990A (en) Cephalospoline compounds
JPS52125158A (en) Oxothia compound
JPS5318555A (en) Compounds